Regina Reed
Primary Care · Coolville, OHNPI 1255357125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $819 and has fallen 77.7% since, to $183 in 2024.
Across 141 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$413
- Novo Nordisk$392
- Corcept Therapeutics$231
- Lilly USA, LLC$180
- Bayer$148
- Sanofi-aventis U.S. LLC$112
- plus $808 from 18 others
What the payments were for
- Food & beverage$2,285100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 23 | $413 |
| Novo Nordisk | 30 | $392 |
| Corcept Therapeutics | 14 | $231 |
| Lilly USA, LLC | 12 | $180 |
| Bayer | 9 | $148 |
| Sanofi-aventis U.S. LLC | 7 | $112 |
| Abbott | 6 | $96 |
| Alkermes, Inc. | 3 | $80 |
| AbbVie | 4 | $74 |
| Insulet Corporation | 3 | $69 |
| Medtronic | 4 | $63 |
| Astellas Pharma US Inc | 4 | $62 |
| Zealand Pharma US, Inc. | 3 | $52 |
| Tandem Diabetes Care, Inc. | 3 | $46 |
| AstraZeneca | 3 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Mannkind Corporation | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Boehringer Ingelheim | 2 | $31 |
| Merck | 1 | $22 |
| Biogen | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
How this compares
$2,285 in reported general payments places this provider in the 85th percentile of 321 primary care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 32 | $49,445 |
| JardianceEmpagliflozin | 36 | $48,572 |
| MounjaroTirzepatide | 19 | $26,502 |
| FarxigaDapagliflozin Propanediol | 16 | $21,469 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 30 | $19,991 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $14,385 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $9,495 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $6,674 |
| Novolog FlexpenInsulin Aspart | 21 | $5,715 |
| V-Go 40Sub-Q Insulin Device, 40 Unit | 13 | $5,674 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $4,985 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 16 | $1,604 |
| Levothyroxine Sodium | 51 | $483 |
| Metformin Hcl | 27 | $198 |
| Metformin Hcl ErMetformin Hcl | 23 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $392 | $49,44532 claims |
| Boehringer IngelheimJardiance | $31 | $48,57236 claims |
| Lilly USA, LLCMounjaro | $180 | $26,50219 claims |
| AstraZenecaFarxiga | $39 | $21,46916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 321 primary care providers in Ohio.
Other primary care in Coolville
- Adine EdwardsSpringfield$14K
- Kelly McKenna TaulbeeHamilton$12K
- Lindsay ChappellFairlawn$11K
- Laura HolligerNorth Canton$10K
- Caitlyn FrantzDayton$10K
- Brandy RichardsCleveland$8K
- Regan HeagenFindlay$8K
- Zachary HaleBeavercreek$7K
- Katherine ElliotWesterville$7K
- Stephanie EmmettMayfield Heights$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.